Masaya Yasutake

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaya Yasutake. Retrieved from https://idiyas.com/inventor/masaya-yasutake

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

3 out of 985

Chugai Seiyaku Kabushiki Kaisha

patents

Years Active: 2017-2026

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12558423 - ANTIBODY-CONTAINING FORMULATION (2026-02-24),

2. 10898572 - Stable protein-containing preparation containing argininamide or analogous compound thereof (2021-01-26),

3. 9574005 - Stable Protein-containing preparation containing argininamide or analogous compound thereof (2017-02-21),

Title: Masaya Yasutake: Innovator in Protein Stabilization

Introduction

Masaya Yasutake is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of protein stabilization, particularly in the context of antibody solutions. With a total of 3 patents, Yasutake's work has garnered attention for its innovative approaches to enhancing the stability of protein formulations.

Latest Patents

Yasutake's latest patents focus on the development of stable protein-containing preparations that incorporate argininamide or analogous compounds. His research demonstrates that the addition of argininamide or valinamide to highly concentrated antibody solutions leads to remarkable stabilization, especially against photostress. This advancement has the potential to improve the efficacy and shelf-life of therapeutic proteins.

Career Highlights

Masaya Yasutake is currently associated with Chugai Pharmaceutical Co., Ltd., where he continues to explore innovative solutions in biopharmaceuticals. His expertise in protein chemistry and formulation science has positioned him as a key player in the industry.

Collaborations

Yasutake collaborates with Daisuke Kameoka, leveraging their combined expertise to drive advancements in protein stabilization technologies.

Conclusion

Masaya Yasutake's contributions to the field of protein stabilization are noteworthy, and his innovative patents reflect his commitment to enhancing the effectiveness of therapeutic proteins. His work continues to influence the biopharmaceutical landscape positively.

Profile summary based on public USPTO records.